# Enveda --- ## Pages - [Atopic Dermatitis Follow Up](https://enveda.com/atopic-dermatitis-follow-up/) - [AD Trial Survey](https://enveda.com/ad-trial-survey/) - [Terms of Service](https://enveda.com/terms-of-service/) - [Clinical Trials - Eczema (Espanol)](https://enveda.com/clinical-trials-eczema-espanol/) - [Atopic Dermatitis Clinical Trial](https://enveda.com/atopic-dermatitis-trial/) - [Animal Health](https://enveda.com/animal-health/) - [Survey](https://enveda.com/survey/) - [Env308](https://enveda.com/env308/) - [Alchemy 2025 Video](https://enveda.com/alchemy-2025-video/) - [Alchemy Information](https://enveda.com/alchemy2025/) - [Alchemy](https://enveda.com/alchemy/) - [Careers](https://enveda.com/careers/) - [Contact](https://enveda.com/contact/) - [News](https://enveda.com/news/) - [In-Veda](https://enveda.com/in-veda/) - [Purpose](https://enveda.com/purpose/) - [People](https://enveda.com/people/) - [Platform](https://enveda.com/platform/) - [Pipeline](https://enveda.com/pipeline/) - [Privacy Policy](https://enveda.com/privacy-policy/): Who we are Suggested text: Our website address is: https://enveda. com. Comments Suggested text: When visitors leave comments on the... - [Home](https://enveda.com/) --- ## Blog - [In-Veda: Insights into Enveda. Insights into knowledge.](https://enveda.com/in-veda-insights-into-enveda-insights-into-knowledge/) - [Rediscovering Therapeutic Roots: How Ethnobotany Aids Drug Discovery](https://enveda.com/rediscovering-therapeutic-roots-how-ethnobotany-aids-drug-discovery/) - [Breaking Barriers: Simultaneous Target and Drug Discovery at Scale](https://enveda.com/breaking-barriers-simultaneous-target-and-drug-discovery-at-scale/) - [Hacking the Unknown](https://enveda.com/hacking-the-unknown/) - [Artemisinins, Malaria, and The Quest to Systematize Collaboration between Nature and Scientists (Cures and Nobel Prizes)](https://enveda.com/artemisinins-malaria-and-the-quest-to-systematize-collaboration-between-nature-and-scientists-cures-and-nobel-prizes/) - [Survival of the Fittest: Nature's Solution to Surviving Clinical Trials](https://enveda.com/survival-of-the-fittest-natures-solution-to-surviving-clinical-trials/) - [PRISM: A foundation model for life’s chemistry](https://enveda.com/prism-a-foundation-model-for-lifes-chemistry/) - [The Chemical Code: An Opportunity Bigger Than The Genetic Code](https://enveda.com/the-chemical-code-opportunity/) --- ## News - [Enveda Appoints Christopher K. Porter, MBA, JD as Senior Vice President, Clinical Operations](https://enveda.com/news/enveda-appoints-christopher-k-porter-mba-jd-as-senior-vice-president-clinical-operations/) - [Enveda Reports Positive Results for ENV-294 in a Phase 1b Clinical Trial of Patients with Moderate-to-Severe Atopic Dermatitis](https://enveda.com/news/enveda-reports-positive-results-for-env-294-in-a-phase-1b-clinical-trial-of-patients-with-moderate-to-severe-atopic-dermatitis/) - [Enveda named one of the Most Innovative Companies in biotech by Fast Company](https://enveda.com/news/the-most-innovative-biotech-companies-of-2026/) - [Enveda Advances Third Asset to the Clinic With US FDA IND Clearance and Phase 1 Initiation of ENV-6946, a First-in-Class Oral “Multi-Biologic in a Pill” for Inflammatory Bowel Disease](https://enveda.com/news/enveda-advances-third-asset-to-the-clinic-with-us-fda-ind-clearance-and-phase-1-initiation-of-env-6946/) - [Enveda Announces US FDA IND Clearance and First Patient Dosed in Phase 1 Trial of ENV-308, a First-in-Class Oral Therapy for Obesity; Appoints Nadeem Sarwar, Ph.D., MPharm, MPhil, to Lead...](https://enveda.com/news/enveda-announces-us-fda-ind-clearance-and-first-patient-dosed-in-phase-1-trial-of-env-308-a-first-in-class-oral-therapy-for-obesity-appoints-nadeem-sarwar-ph-d-mpharm-mphil-to-lead-metabolic-di/) - [Enveda Initiates Phase 2 Clinical Trials of ENV-294, a First-in-Class Oral Therapy in Atopic Dermatitis and Asthma](https://enveda.com/news/enveda-initiates-phase-2-clinical-trials-of-env-294-a-first-in-class-oral-therapy-in-atopic-dermatitis-and-asthma/) - [Enveda Raises $150 Million To Use AI To Develop Drugs From Nature](https://enveda.com/news/enveda-raises-150-million-to-use-ai-to-develop-drugs-from-nature/) - [Enveda Gets New Backing to Scour Nature for Promising Compounds](https://enveda.com/news/enveda-gets-new-backing-to-scour-nature-for-promising-compounds/) - [Enveda raises $150M for drug development, reaching unicorn status](https://enveda.com/news/enveda-raises-150m-for-drug-development-reaching-unicorn-status/) - [Enveda collects another $150M for I&I drug, sprawling pipeline of preclinical assets](https://enveda.com/news/enveda-collects-another-150m-for-ii-drug-sprawling-pipeline-of-preclinical-assets/) - [Enveda CEO Reveals How It Will Deploy $150M in Series D Funding](https://enveda.com/news/enveda-ceo-reveals-how-it-will-deploy-150m-in-series-d-funding/) - [Exclusive: Biotech's Latest Unicorn Uses AI to Mine Nature's Medicine Chest](https://enveda.com/news/enveda-cracking-the-chemical-code-of-life-with-ai/) - [Enveda Raises $150M Series D Funding to Reach Unicorn Status, Enrolls First Patient in Lead Program, and Adds Mikael Dolsten to Board of Directors](https://enveda.com/news/enveda-raises-150m-series-d-funding-to-reach-unicorn-status-enrolls-first-patient-in-lead-program-and-adds-mikael-dolsten-to-board-of-directors/) - [Enveda: Cracking the chemical code of life with AI](https://enveda.com/news/ai_challenger_enveda/) - [Enveda Reports Favorable Phase 1 Safety for Novel Oral Anti-Inflammatory, Launches Phase 1b Trial in Atopic Dermatitis](https://enveda.com/news/enveda-reports-favorable-phase-1-safety-for-novel-oral-anti-inflammatory-launches-phase-1b-trial-in-atopic-dermatitis/) - [America's Greatest Startup Workplaces 2025](https://enveda.com/news/americas-greatest-startup-workplaces-2025/) - [2025 America's Best Startup Employers](https://enveda.com/news/2025-americas-best-startup-employers/) - [Enveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M](https://enveda.com/news/enveda-gains-backing-from-sanofi-to-advance-ai-driven-drug-discovery-to-clinical-trials-bringing-total-series-c-financing-to-150m/) - [Enveda Expands into Asthma with First-in-Class Lead Asset ENV-294 and Assembles World-Class Advisory Board](https://enveda.com/news/enveda-expands-into-asthma-with-first-in-class-lead-asset-env-294-and-assembles-world-class-advisory-board/) - [Enveda Welcomes Jason Kim as Chief Financial Officer](https://enveda.com/news/enveda-welcomes-jason-kim-as-chief-financial-officer/) - [Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates](https://enveda.com/news/enveda-closes-130m-series-c-funding-to-deliver-multiple-clinical-readouts-from-a-pipeline-of-10-development-candidates/) - [AI Drug Discovery Startup Enveda Raises $130 Million](https://enveda.com/news/ai-drug-discovery-startup-enveda-raises-130-million/) - [Enveda Announces First Candidate Discovered From Nature Using AI Advances to Clinical Trials](https://enveda.com/news/enveda-announces-first-candidate-discovered-from-nature-using-ai-advances-to-clinical-trials-2/) - [Enveda Biosciences Hires Chief Medical Officer to Advance Its Rich Pipeline of Therapeutic Programs into the Clinic](https://enveda.com/news/pr-enveda-biosciences-hires-chief-medical-officer-to-advance-its-rich-pipeline-of-therapeutic-programs-into-the-clinic/) - [Enveda Biosciences Announces $55M in New Funding to Accelerate Platform and Advance Multiple Candidates to Clinical Trials](https://enveda.com/news/enveda-biosciences-announces-55m-in-new-funding-to-accelerate-platform-and-advance-multiple-candidates-to-clinical-trials/) - [Enveda raises $55M to combine ancient remedies with AI for drug discovery](https://enveda.com/news/enveda-raises-55m-to-combine-ancient-remedies-with-ai-for-drug-discovery/) - [Enveda translates life’s chemistry into medicines](https://enveda.com/news/enveda-translates-lifes-chemistry-into-medicines/) - [Enveda Biosciences Announces Microsoft Collaboration and Reveals Foundation Model to “Read and Translate” Chemistry](https://enveda.com/news/pr-enveda-biosciences-announces-microsoft-collaboration-and-reveals-foundation-model-to-read-and-translate-chemistry/) - [Enveda Biosciences unveils new AI algorithm to unlock nature’s chemical code](https://enveda.com/news/enveda-biosciences-unveils-new-ai-algorithm-to-unlock-natures-chemical-code/) - [Enveda Biosciences Announces Oversubscribed Series B1 Bringing Total Round to US$119 Million](https://enveda.com/news/enveda-biosciences-announces-oversubscribed-series-b1-bringing-total-round-to-us119-million/) - [TRANSFORMing natural product drug discovery: machine learning for high-fidelity chemical property prediction from metabolomics data](https://enveda.com/news/transforming-natural-product-drug-discovery-machine-learning-for-high-fidelity-chemical-property-prediction-from-metabolomics-data/) - [Enveda Biosciences Closes $68-million Combined Series B Equity and Debt Financing](https://enveda.com/news/enveda-biosciences-closes-68-million-combined-series-b-equity-and-debt-financing/) - [Enveda Biosciences Closes $51M Series A Financing Led by Lux Capital](https://enveda.com/news/enveda-biosciences-closes-51m-series-a-financing-led-by-lux-capital/) --- ## People - [Akshay Rai](https://enveda.com/person/akshay-rai/) - [Mikael Dolsten](https://enveda.com/person/mikael-dolsten/) - [Jason Kim](https://enveda.com/person/jason-kim-2/) - [Viswa Colluru, PhD](https://enveda.com/person/viswa-colluru-phd/) - [Zavain Dar](https://enveda.com/person/zavain-dar/) - [Pegah Ebrahimi](https://enveda.com/person/pegah-ibrahimi/) - [Alexander Adibekian, Phd](https://enveda.com/person/alexander-adibekian-phd/) - [Connor Coley, Phd](https://enveda.com/person/connor-coley-phd/) - [Ryan Shenvi, PhD](https://enveda.com/person/ryan-shenvi-phd/) - [Benjamin Cravatt, PhD](https://enveda.com/person/benjamin-cravatt-phd/) - [Pieter Dorrestein, PhD](https://enveda.com/person/pieter-dorrestein-phd/) - [Ethan Weiner, MD](https://enveda.com/person/ethan-weiner-md/) - [James Mackay, PhD](https://enveda.com/person/james-mackay-phd/) - [Brian Feagan, MD](https://enveda.com/person/brain-feagan-md/) - [Jonathan Silverberg, MD, PhD, MPH](https://enveda.com/person/jonathan-silverberg-md-phd-mph/) - [Christian Scherrer](https://enveda.com/person/christian-scherr/) - [Rohit Sharma](https://enveda.com/person/rohit-sharma/) - [Tendai Chisowa, PhD](https://enveda.com/person/tendai-chisowa-phd/) - [Soumoditya Dey](https://enveda.com/person/soumoditya-dey/) - [Robert Buckley](https://enveda.com/person/robert-buckley-2/) - [PK Jadhav, PhD](https://enveda.com/person/pk-jadhav-phd/) - [Niranjan Rao, PhD, FCP](https://enveda.com/person/niranjan-rao-phd/) - [José Trevejo, MD, PhD](https://enveda.com/person/jose-trevejo-md-phd/) - [Jason Tejani](https://enveda.com/person/jason-tejani/) - [Hannah Gordon, PhD](https://enveda.com/person/51-2/) - [August Allen](https://enveda.com/person/hannah-gordon-2/) - [Bigyan Bista, PhD](https://enveda.com/person/hannah-gordon-3/) - [Viswa Colluru, PhD](https://enveda.com/person/hannah-gordon/) - [Inhwan Kim, PharmD](https://enveda.com/person/viswa-colluru/) - [Eswar Bonangi](https://enveda.com/person/robert-buckley/) - [Daniel Wee, PhD](https://enveda.com/person/daniel-wee/) --- # # Detailed Content ## Pages - Published: 2026-05-05 - Modified: 2026-05-05 - URL: https://enveda.com/atopic-dermatitis-follow-up/ --- - Published: 2026-03-26 - Modified: 2026-03-27 - URL: https://enveda.com/ad-trial-survey/ --- - Published: 2026-03-26 - Modified: 2026-03-26 - URL: https://enveda.com/terms-of-service/ --- - Published: 2026-01-29 - Modified: 2026-01-29 - URL: https://enveda.com/clinical-trials-eczema-espanol/ --- - Published: 2026-01-26 - Modified: 2026-02-05 - URL: https://enveda.com/atopic-dermatitis-trial/ --- - Published: 2026-01-21 - Modified: 2026-01-21 - URL: https://enveda.com/animal-health/ --- - Published: 2026-01-15 - Modified: 2026-01-15 - URL: https://enveda.com/survey/ --- - Published: 2025-12-19 - Modified: 2025-12-19 - URL: https://enveda.com/env308/ --- - Published: 2025-11-24 - Modified: 2025-11-24 - URL: https://enveda.com/alchemy-2025-video/ --- - Published: 2025-11-07 - Modified: 2025-11-07 - URL: https://enveda.com/alchemy2025/ --- - Published: 2025-06-26 - Modified: 2025-08-20 - URL: https://enveda.com/alchemy/ --- - Published: 2024-10-25 - Modified: 2025-01-09 - URL: https://enveda.com/careers/ --- - Published: 2024-10-15 - Modified: 2024-12-17 - URL: https://enveda.com/contact/ --- - Published: 2024-10-15 - Modified: 2024-10-30 - URL: https://enveda.com/news/ --- - Published: 2024-10-15 - Modified: 2025-01-30 - URL: https://enveda.com/in-veda/ --- - Published: 2024-10-15 - Modified: 2025-06-04 - URL: https://enveda.com/purpose/ --- - Published: 2024-10-15 - Modified: 2025-10-02 - URL: https://enveda.com/people/ --- - Published: 2024-10-15 - Modified: 2024-12-10 - URL: https://enveda.com/platform/ --- - Published: 2024-10-15 - Modified: 2026-04-13 - URL: https://enveda.com/pipeline/ --- - Published: 2024-10-14 - Modified: 2026-03-26 - URL: https://enveda.com/privacy-policy/ --- - Published: 2024-10-14 - Modified: 2025-09-05 - URL: https://enveda.com/ --- --- ## Blog --- ## News --- ## People ---